You're reading the free version. Trader adds the live tape and alerts.
Start tracking
INBX Buy Disclosure
Lappe Mark · SEC Form 4 · Filed Sep 28, 2026
Buy
Calculated transaction value
$305.11K
Lappe Mark Chief Executive Officer
INBX
Inhibrx Biosciences
INBX
Transaction date
Sep 28, 2026
Public filing date
Sep 28, 2026
Filing lag
Filed same day
INBX daily price context
Close on/before transaction
$101.71
Sep 28, 2026
First close after public filing
$104.83
Sep 29, 2026
30-day return after filing
-30.09%
Through Oct 28, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,000 shares @ $101.7
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001366074-26-000004
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$998.78K
Buys / sales
4 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Inhibrx Biosciences, Inc. INBX | Buy | Sep 28, 2026 | $148.32K |
| Inhibrx Biosciences, Inc. INBX Current | Buy | Sep 28, 2026 | $305.11K |
| Inhibrx Biosciences, Inc. INBX | Buy | Sep 25, 2026 | $328.63K |
| Inhibrx Biosciences, Inc. INBX | Buy | Sep 25, 2026 | $216.73K |